Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)
PHASE2CompletedINTERVENTIONAL
Enrollment
164
Participants
Timeline
Start Date
October 31, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Conditions
Major Depressive Disorder
Interventions
DRUG
ETS6103 (low dose)
DRUG
ETS6103 (high dose)
DRUG
Amitriptyline
Trial Locations (1)
G20 OXA
CPS Research, Glasgow
All Listed Sponsors
lead
e-Therapeutics PLC
INDUSTRY
NCT02014363 - Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter